Takeda's sales-op expansion continues

Share this article:

Japanese drugmaker Takeda will launch a new subsidiary in Tel Aviv, the company said today. The announcement marks the sixth “sales entity” the company has opened this year, following Algeria, Peru, Singapore, Ecuador and Vietnam. Takeda Israel Ltd. will supervise sales and marketing for the drugmaker's portfolio in the region. The company couched this as another evolutionary step in its plan to "reinforce growth markets."

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Novartis said to be stepping out of HCV

Novartis is said to have relinquished rights to an investigational hep. C treatment, signaling its exit from the therapeutic space, according to a former partner's announcement.

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.